I appreciate your comments and respect your position.

New Post Public Reply Private Reply Replies (2) Message Board
joey68 snakeclaw #472
I appreciate your comments and respect your position. Seeing this board lacks in contributions (most people read and never post), it is nice to get some feedback.

First off, I understand what you are saying, but to begin, it is important to remember that I am not the spokesperson for Spectrascience. I'm simply an investor like everyone else. None of my posts are meant to be investment advice and quite often I mention no one should invest more than they can afford to lose. When you said, "however many of us are loosing our ass", it's important to remember that all investors, including you and me, have the ability to sell at any time. Continuing to remain invested in a company which you consider to be 'bleeding' and in a 'death spiral' may be a sign that this stock is not right for you. Something must be keeping you invested, right? If not, you would have sold long ago. By following the rule of not investing more than you can afford to lose, even if SCIE completely fails and we lose everything, it shouldn't affect us financially because we didn't invest more than we can afford to lose.

This is not to brag or anything, because I have no reason to try to impress random, online strangers: The majority of my posts (and I have over 200) in here have actual, physical DD with links, articles, government findings, research, human studies, etc etc. In my opinion, they all point towards success. Obviously SCIE could fail. Nothing is guaranteed in life. I said many times in previous posts that I would sell my entire SCIE position in a second if I believed this was going no where. But, to base it off of a chart... to sell simply because the price is lower today than it was yesterday..? That's not how I invest. I've been invested in countless stocks that I thought were going to succeed and then in the blink of an eye I sold because something didn't feel right. I'd do the same with SCIE if necessary.

You mentioned:
"i'm sure you can figure out a way to explain to us investors how this is a great investment no matter how low the pps gets"

My response to this is twofold:
First, I see SCIE as a great investment. It's up to you and everyone else to decide if they see SCIE as a great investment as well. Don't invest based on my posts (I say this in many of my posts and is also in my disclaimer below).

Second, I don't only post 'how great' SCIE is. Did you read my previous posts on how I hate SCIE's website for being out of date? They have 2014 articles on their front page. SCIE isn't perfect.

I also believe that perhaps you haven't read my previous posts (not that you have to, but they would clarify some of your concerns).

You said:
"the wavestat4 does work, and if it were really a god-send product i think the world would be clamoring for this device and yet it hasn't happened yet"

In a previous post, I posted (with a link) an article which explains why medical devices can take a decade or longer to go from rough draft to clinical usage. Why would the world clamor for the WavSTAT right now? The technology is brand new. Even being 10 years or more in the making, its still a new idea. When the first automobiles came out, it took years upon years upon years before people really figured out they were better than horse and carriage. People don't like change. Standard biopsies (cut it out and send it to the lab) is what we know. Our generation and our parents generation only knew of this biopsy and it is what makes us comfortable. It will take years before optical biopsies completely replace standard biopsies, but I believe it will happen.

In reference to VHS vs Betamax, you said, " it was better in every aspect" but this isn't actually true. One of the main reasons why VHS took the market away from Betamax was because VHS could record several hours while Betamax could only record one hour. And so, to use this argument in comparison to the WavSTAT, standard biopsies are like Betamax and optical biopsies are like VHS. Yes, two companies, Betamax had a product. But in the end, consumers wanted a tape that could record longer times and VHS won out. I see the same thing happening with the WavSTAT. Sure, standard biopsies work. But ultimately, optical biopsies are going to come out on top leaving standard biopsies in the dust.

In response to your comment, "is it possible there are other competing devices and technologies and that the wavestat4 isn't the only game in town?"..

Another previous post of mine listed all the competitors of the WavSTAT4. But SCIE holds many patents, and many of the competitors products cost thousands of more dollars compared to the WavSTAT.

You also mentioned:
" one of the light detection methods is spectroscopy, of which a company is already doing that in many countries. "

I'm not sure if you know this, but the WavSTAT 4 uses Laser Induced Fluorescence Spectroscopy . This IS the technology of the WavSTAT.

In conclusion, thanks for the post. It's always good to reevaluate my thinking and my investment decisions, but I'm still convinced the WavSTAT4 is at the forefront of it all. In the long run, even if it takes 3 more years to reach a penny, it wouldn't bother me because I'm a long. And until I find any article listing the WavSTAT4 doesn't work, i'll continue to remain invested. But of course, you do as you see fit for your own personal investment and don't invest based on this or any post.

Take care!

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 562

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 88

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 395

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 193

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 437

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 67

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 619

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 461

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 573

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

Siemens Expands Presence with New Facility in Tech City

Updated Category News Views 643

Siemens Launches New Facility at San Felasco Tech City Siemens is excited to reveal a major development in its journey toward innovation and sustainability. The company will be setting up a 6,500 square foot facility at San Felasco Tech City, a top-notch business park that prioritizes cutting-edge technologies along with environmental stewardship. About San Felasco Tech...

Continue Reading
Fitting Futures: A Transformative Journey in Student Support

Updated Category News Views 137

Fitting Futures: A New Chapter for Student Support In a refreshing turn of events, a nonprofit dedicated to empowering students has undergone a remarkable transformation. The White Cane Foundation, known for its unwavering support to students in need, has rebranded itself as Fitting Futures. This name change signifies a heartfelt commitment to ensuring that every student...

Continue Reading
Gaming and Leisure Properties Expands with New Casino Venture

Updated Category News Views 266

Gaming and Leisure Properties Seizes New Opportunities Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) is making waves in the gaming and hospitality industry with its recent agreement to acquire land for the much-anticipated Live! Casino and Hotel Virginia. This exciting project, which involves a joint venture with The Cordish Companies and Bruce Smith Enterprise,...

Continue Reading
Exploring the Expanding Polypropylene Compounds Market

Updated Category News Views 149

Expansion of the Polypropylene Compounds Market As the world progresses towards more sustainable and lightweight materials, the polypropylene compounds market is projected to reach a staggering USD 24.8 billion by 2030. This growth, which is rooted in a compound annual growth rate (CAGR) of 6.2%, is largely driven by the increasing need for lightweight materials in...

Continue Reading
Pimax Unveils Cutting-Edge VR Headsets at CES 2026 Event

Updated Category News Views 250

Exciting Innovations in VR Technology at CES 2026 LAS VEGAS, January 2026 – Pimax has made headlines at the Consumer Electronics Show (CES) this year with the release of its next-gen lineup of PCVR headsets. The company has showcased its latest model, the Crystal Super Micro-OLED, alongside the Dream Air and Dream Air SE. These headsets highlight Pimax's dedication to...

Continue Reading